New York State Common Retirement Fund raised its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 9.1% in the 4th quarter, Holdings Channel reports. The firm owned 61,211 shares of the company’s stock after purchasing an additional 5,126 shares during the quarter. New York State Common Retirement Fund’s holdings in Pediatrix Medical Group were worth $803,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Quest Partners LLC increased its stake in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after buying an additional 622 shares during the period. Quarry LP lifted its stake in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after acquiring an additional 1,662 shares during the period. FMR LLC boosted its holdings in Pediatrix Medical Group by 220.6% in the third quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after acquiring an additional 6,771 shares during the last quarter. Quantinno Capital Management LP acquired a new stake in Pediatrix Medical Group during the 3rd quarter valued at approximately $138,000. Finally, SG Americas Securities LLC bought a new position in Pediatrix Medical Group during the 4th quarter worth approximately $171,000. 97.71% of the stock is owned by institutional investors and hedge funds.
Pediatrix Medical Group Price Performance
Shares of NYSE MD opened at $14.46 on Tuesday. The firm has a market capitalization of $1.24 billion, a P/E ratio of -12.05, a P/E/G ratio of 1.74 and a beta of 1.57. The firm’s 50-day moving average price is $13.99 and its 200-day moving average price is $13.19. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on the stock. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. UBS Group increased their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday, February 21st. Jefferies Financial Group lifted their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Mizuho upped their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. Finally, Macquarie assumed coverage on Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price for the company. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Pediatrix Medical Group has an average rating of “Hold” and an average price target of $17.08.
Check Out Our Latest Stock Report on MD
Pediatrix Medical Group Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Recommended Stories
- Five stocks we like better than Pediatrix Medical Group
- Stock Sentiment Analysis: How it Works
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is the FTSE 100 index?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What Are Treasury Bonds?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.